ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet


















New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
Melinta goes bankrupt / Never let a good crisis go to waste
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
UK to expand NHS Subscription Pilot! Consultation Period launches
FDA analysis of 40-years of antibacterial development: Dheman et al.
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
In Praise of Non-Inferiority
FDA and EMA regulatory updates / Fireside chat during the 4th AMR Conference
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet

The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet